je.st
news
Adaptive Biotechnologies Receives $2.53 million Phase II Sbir to...
2013-09-14 06:04:40| Logistics - Topix.net
Adaptive Biotechnologies announced today that it received a $2.53 million Phase II Small Business Innovation Research award from the National Heart, Lung, and Blood Institute, a division of the NIH, to commercialize a test to measure the ability of a cancer patient's adaptive immune system to fight infection after a cord blood transplant.
Tags: to
million
phase
receives
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||